SRRK
Scholar Rock Holding CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.29B
P/E Ratio
—
EPS
$-3.45
Beta
0.69
52W High
$52.19
52W Low
$27.07
50-Day MA
$47.77
200-Day MA
$41.86
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious diseases in which protein growth factor signaling plays a critical role. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-211.58M |
| EBITDA | $-407.97M |
| Operating Margin | 0.00% |
| Return on Equity | -138.90% |
| Return on Assets | -54.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.32 |
| Price-to-Book | 19.18 |
| Price-to-Sales (TTM) | 13.14 |
| EV/Revenue | 8.22 |
| EV/EBITDA | -2.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $119.83M |
| Float | $91.80M |
| % Insiders | 0.76% |
| % Institutions | 116.56% |
Historical Volatility
HV 10-Day
46.51%
HV 20-Day
47.19%
HV 30-Day
42.79%
HV 60-Day
54.92%
HV Rank
8.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($59.31 target)
3
Strong Buy15
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026